Previous Close | 28.57 |
1-Year Change | -20.35% |
6-Months Change | 22.15% |
3-Months Change | 18.2% |
Moving Avg (50d) | 26.426 |
Moving Avg (200d) | 27.001 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.35B |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | 20.65% |
Net Profit Margin (ttm) | -6.52% |
Return On Assets (ttm) | -4.13% |
EPS (ttm) | -0.54 |
PE Ratio (ttm) | -52.91 |
Dividend Yield | % |
Asset Description: | AtriCure, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-10-15 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
27.999 | 27.141 | 26.57 | 25.713 | 24.284 | 22.856 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |